Abstract:Purpose: To evaluate the long-term tolerance and outcome of patients irradiated with an electron beam technique used since 2007 on the chest wall and lymph node areas after mastectomy for non-metastatic locally advanced breast carcinoma. Patients and methods: All patients irradiated with an improved electron beam technique after mastectomy for non-metastatic breast carcinoma between 2007 and 2011 at Institut Curie (France) were included in this descriptive study. The technique has already been described in other studies, as has its 5-year tolerance and non-inferiority compared to photon irradiation. Acute and chronic toxicity were collected using CTCAE v 3.0. A clinical examination was carried out each week during the radiotherapy and at each 6 months consultation with one mammogram per year at the Institut Curie for at least 5 years. The patients then continued to be followed either at the Institut Curie or in private practice with a good transmission of outpatient consultations, thanks to a system of forms to be completed and integrated into the electronic files. Quantitative and qualitative data are defined by mean and proportion. Statistical comparisons were made by computer using the Chi2 test and Fisher's exact test for categorical variables. Recurrence-free survival was defined as the time between the end of treatment and the date of recurrence or death. Overall survival was defined in the same way without taking into account recurrences. Patients who did not report any events were censored at the date of last news. Results: Of the 796 patients included, 51.3% had multifocal lesions, 10.1% had triple negative status, and 18.8% displayed overexpression of the Her2 receptor, 196 (24.6%) patients received neoadjuvant chemotherapy and 208 (26.1%) systemic treatment during radiotherapy (chemotherapy or targeted therapy); 514 (64.6%) had at least one positive lymph node. The internal mammary chain (IMC) was irradiated in 85.6% of cases, the supraclavicular areas in 88.3% of cases, the infraclavicular in 77.9% of cases and the axillary area in 14.9% of cases. With a median follow-up of 113 months (range: 2-164 months), locoregional recurrence-free survival and overall 10-year survival was respectively 94.02%, (95% CI: 92.13-98.94) and 79.84% (95% CI: 76.83-82.97). Median survival was not reached. In the long term, 29.6% of patients had telangiectasias (grade 1: 23.3%, grade 2: 5.2%, grade 3: 1.1%). There were 279 patients (35.1%) with secondary breast reconstruction on average 21 months after all treatments. IMC irradiation was not associated with a majority of pulmonary toxicity. Thirty-five patients developed chronic heart disease after radiotherapy, 30 of whom had received anthracyclines and 9 had received traztuzumab. Three of these reported a coronary ischaemic event, including 2 irradiated on the left and 1 on the right, the 4 were irradiated in the vicinity of the IMC and the other lymph node areas, but presented many other cardiovascular risk factors (between 2 and 4). During follow-up, 4.9% of patients had a contralateral recurrence (n=39) and 5.5% had a second non-breast cancer (n=44), of the 6 bronchopulmonary cancers diagnosed, none appeared to be related to chest wall radiotherapy. Conclusion: This study confirms that the improved postmastectomy electron beam radiation therapy technique is well-tolerated after nearly 10 years of follow-up.

[Electron Arc Therapy: Application of Chest Wall Irradiation after Mastectomy].

A dosimetric comparison of the tangential beams IMRT with multifield beams IMRT of the chest wall in postmastectomy breast cancer recurrent patients

Immobilization-assisted Abdominal Deep Inspiration Breath-Hold in Post-Mastectomy Radiotherapy of Left-Sided Breast Cancer with Internal Mammary Chain Coverage

Postmastectomy chest wall radiotherapy with single low-energy electron beam: An assessment of outcome and prognostic factors.

Electrochemotherapy of chest wall breast cancer recurrence

Long-term efficacy and tolerance of a technique for postmastectomy electron beam radiation therapy of the unreconstructed chest wall and lymph node areas for non-metastatic breast cancers

Radiofrequency Heat-Enhanced Chemotherapy for Breast Cancer: Towards Interventional Molecular Image-Guided Chemotherapy.

Optimization of Combined Electron and Photon Beams for Breast Cancer

Post Mastectomy Linac IMRT Irradiation of Chest Wall and Regional Nodes: Dosimetry Data and Acute Toxicities

Dosimetric Comparison for Volumetric Modulated Arc Therapy and Intensity-Modulated Radiotherapy on the Left-Sided Chest Wall and Internal Mammary Nodes Irradiation in Treating Post-Mastectomy Breast Cancer

Integrated IMRT Vs Segmented 3D-CRT of the Chest Wall and Supraclavicular Region for Breast Cancer after Modified Radical Mastectomy: an 8-Year Follow-Up

Advances in radiation therapy for early stage breast cancer

Radiotherapy for 64 Cases with Postoperative Chestwall Local Recurrence of Breast Cancer

Comparison of the Effects of Two Types of Multileaf Collimators on Tumor Control Probability in Radiotherapy for Breast Cancer after Conservative Surgery Based on the EUD Model ⁎

Irradiation of the Chest Wall and Regional Nodes As an Integrated Volume with IMRT for Breast Cancer: Acute Toxicity from a Pilot Study

Radiotherapy for chest wall recurrence of breast cancer after mastectomy

Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy.

Artificial Intelligence-Based Automated Treatment Planning of Postmastectomy Volumetric Modulated Arc Radiotherapy

Radiotherapy for and Prognosis of Breast Cancer Patients with Local-Regional Recurrence after Mastectomy

SPACES: Our Team's Experience in Lung Tumor Microwave Ablation

Changes in postmastectomy radiotherapy targets in breast cancer in China between 1999 and 2008: an epidemiological study